Form 8-K - Current report:
SEC Accession No. 0001213900-20-006311
Filing Date
2020-03-13
Accepted
2020-03-13 16:10:23
Documents
6
Period of Report
2020-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea119575-8k_aytubio.htm 8-K 38196
2 FORM OF WARRANT ea119575ex4-1_aytubio.htm EX-4.1 107186
3 FORM OF PLACEMENT AGENT'S WARRANTS ea119575ex4-2_aytubio.htm EX-4.2 83542
4 OPINION OF DORSEY & WHITNEY LLP ea119575ex5-1_aytubio.htm EX-5.1 23800
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED MARCH 12, 2020, BY AND BETWEEN THE ea119575ex10-1_aytubio.htm EX-10.1 182206
6 PRESS RELEASE DATED MARCH 12, 2020 ea119575ex99-1_aytubio.htm EX-99.1 16845
  Complete submission text file 0001213900-20-006311.txt   453099
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 20712752
SIC: 2834 Pharmaceutical Preparations